Wettig Thane's Form 4 filing
Kyntra Bio, Inc. (KYNB) · filed Jun 9, 2023
- Accession no.
- 0001209191-23-036066
- Filed
- Jun 9, 2023
- Trade date
- Jun 7, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $30.0K. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001209191-23-039157 (Jun 22, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wettig ThaneCIK 0001815638 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2023 | Common Stock | SSaleDisposed | −472 | $17.04 | −$8,042.88 | 112,681 | Direct | |
| Jun 7, 2023 | Common Stock | SSaleDisposed | −1,286 | $17.04 | −$21,913.44 | 111,395 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.